Aethlon Medical (AEMD) trades higher as investors digest a merger where shareholders are slated to own about 4.75% of the combined company
Market Chameleon (Tue, 22-Sep 11:42 AM)
AEMD deal spotlight: law firm probes whether North Immunology merger terms are fair
Market Chameleon (Fri, 18-Sep 9:58 AM)
Aethlon Medical shareholders could own just 4.75% of the combined company in North Immunology deal, law firm says
Market Chameleon (Thu, 17-Sep 9:52 AM)
Aethlon Medical Plans Merger With North Immunology Backed by an Oversubscribed $180 Million Financing
Market Chameleon (Thu, 17-Sep 7:05 AM)
